Add-on Acquisition • Life Science

Consegna Pharma Acquires Fathom Pharma

On April 19, 2022, Consegna Pharma acquired life science company Fathom Pharma

Acquisition Context

This is Consegna Pharma’s 1st transaction in the Life Science sector.
This is Consegna Pharma’s 1st transaction in the United States.
This is Consegna Pharma’s 1st transaction in Ohio.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	April 19, 2022
Target	Fathom Pharma
Sector	Life Science
Buyer(s)	Consegna Pharma
Deal Type	Add-on Acquisition

Target Company

Fathom Pharma

Blue Ash, Ohio, United States

Fathom Pharma is focused on developing new treatments for moderate to severe chronic pain that addresses the safety and efficacy gaps in the current treatment paradigm. Fathom Pharma is based in Blue Ash, Ohio.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Consegna Pharma

Pittsburgh, Pennsylvania, United States

Category	Company
Sector	Life Science

DESCRIPTION

Consegna Pharma is a drug delivery company providing solutions to reduce deaths from opioid overdoses. Consegna's product pipeline focuses on areas where LAIs offer high therapeutic value, such as addressing high non-adherence, solving specific drug delivery challenges, or reducing side effects. Consegna Pharma is based in Pittsburgh, Pennsylvania.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: Ohio	1 of 1
Country: United States	1 of 1
Year: 2022	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - Ohio M&A - United States M&A - 2022 M&A